1996 (12) TMI 82 - HC - Central Excise

Court affirms 'Boroline' as drug under Tariff Item 14E, dismissing reclassification appeal

The Court upheld the Trial Judge's order classifying 'Boroline' as a drug under Tariff Item 14E, rejecting the appellant's argument for a different ... Classification of goods as drug/medicine versus cosmetic - interpretation of Tariff Items and Chapter Notes for excise classification - binding effect of prior settlement and departmental classification - no estoppel or waiver against statutory classification by accepting exemption or clearance - treatment of claims for excess duty under Section 11BClassification of goods as drug/medicine versus cosmetic - binding effect of prior settlement and departmental classification - Boroline is to be classified as a drug/medicine (patent and proprietary medicine) and not as a cosmetic preparation. - HELD THAT: - The Trial Judge found, on the material before him and on earlier judicial treatment, that Boroline is essentially a drug: its chemical composition (including boric acid and zinc oxide) and its description as an antiseptic boric ointment support classification as a medicinal preparation. The Trial Judge relied upon earlier judicial consideration (including the Allahabad High Court decision and the terms of a prior settlement) and the historical practice of assessment under the tariff item for patent and proprietary medicines. The High Court, after considering submissions about the product's labeling and nature, agreed with the Trial Judge that the product cannot properly be treated as a cosmetic and sustained the conclusion that it is a medicine. [Paras 1, 5, 6, 10, 11]The classification of Boroline as a medicine (to be assessed as patent and proprietary medicine) is upheld.Interpretation of Tariff Items and Chapter Notes for excise classification - The introduction of the Tariff Act, 1985 and the Chapter Notes does not alter the classification conclusion reached earlier. - HELD THAT: - Although counsel contended that the 1985 Tariff Act and its Chapter Notes (and the distinct placement of items under headings corresponding to 30.03 and 33.04) warranted reclassification of Boroline as a cosmetic, the Court examined the relevant tariff items and notes and found no change in law or meaning that would justify departing from the earlier conclusion that Boroline is a medicinal preparation. The Court therefore rejected the contention that Chapter Notes in the 1985 Act mandate a different classification. [Paras 2, 3, 11]The Tariff Act, 1985 and its Chapter Notes do not require reclassification of Boroline as a cosmetic; the prior conclusion that it is a medicine stands.No estoppel or waiver against statutory classification by accepting exemption or clearance - binding effect of prior settlement and departmental classification - Availing of an exemption notification or clearance under a particular tariff heading does not operate as a waiver or estoppel precluding contesting the correct statutory classification. - HELD THAT: - The Court acknowledged that the manufacturer had obtained benefit under an exemption notification and that goods had been cleared under a particular sub-heading pursuant to an appellate court order. Nevertheless, the Court held that acceptance of clearance or the benefit of notification pursuant to such orders does not amount to a waiver or estoppel which would prevent the question of proper classification from being adjudicated. The appellate order permitting clearance and entitling the respondent to applicable notifications was not a concession that precludes contesting classification. [Paras 7, 8]Taking benefit of an exemption or clearing goods under a heading pursuant to orders does not estop the party or preclude judicial determination of the correct classification.Treatment of claims for excess duty under Section 11B - Claims for excess excise duty paid will be dealt with under Section 11B of the Central Excises and Salt Act. - HELD THAT: - The Court recorded that any question as to excess quantum of duty paid by the writ petitioner/respondent would not be adjudicated in the writ proceedings and directed that such claims be dealt with in accordance with Section 11B of the Central Excises and Salt Act. [Paras 12]Claims for refund/adjustment of excess excise duty are to be processed under Section 11B.Final Conclusion: The appeal is dismissed; the High Court sustains the Trial Judge's order classifying Boroline as a medicinal preparation rather than a cosmetic, refuses stay of the operative order, and directs that any claim for excess duty be dealt with under Section 11B. Issues involved:The classification of the product 'Boroline' under Tariff Item 14E or 14F, interpretation of statutory provisions post the Tariff Act of 1985, determination of 'Boroline' as a drug or cosmetic product, reliance on exemption notification dated 1st October, 1985, and the impact of previous settlement and appellate court orders on the classification.Summary:The appeal challenged the Trial Judge's order allowing the writ application regarding the classification of 'Boroline'. The Trial Judge, based on a judgment of the Allahabad High Court, concluded 'Boroline' to be a drug classified under Tariff Item 14E. The appellant argued that post the Tariff Act of 1985, 'Boroline' should not be classified under 14E. However, the Court found no change warranting a different classification. The chemical composition and usage of 'Boroline' supported its classification as a drug rather than a cosmetic product.The appellant contended that 'Boroline' is a cosmetic preparation, not a medicine, citing the product label and composition. However, the Trial Judge determined 'Boroline' to be an antiseptic boric ointment, indicating its medicinal nature. The Court disagreed with the appellant's argument, emphasizing the previous judgment under the Drugs and Cosmetics Act, 1940.Regarding the exemption notification, the appellant claimed that the respondent had availed of the exemption for 'Boroline' falling under 30.03, not 33.04. However, the Court noted that the appellate court's order directed clearance under 33.04, allowing the benefit of any applicable exemptions. The Court highlighted that the acceptance of the appellate court's order did not waive the right to contest the classification.The appellant relied on a Tribunal judgment stating that an erroneous classification can be rectified, but the Court found no grounds for reclassification in this case. Another Supreme Court judgment emphasized interpreting statutes based on popular meaning, supporting the Trial Judge's conclusion that 'Boroline' is a medicine, not a cosmetic product.Ultimately, the Court upheld the Trial Judge's order, dismissing the appeal. Any excess excise duty paid would be addressed under Section 11B of the Central Excises and Salt Act. The prayer for stay of the order's operation was refused.